Terms: = Lymphoma AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Prognosis
3 results:
1. tcf7l2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
[TBL] [Abstract] [Full Text] [Related]
2. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
[TBL] [Abstract] [Full Text] [Related]
3. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
[TBL] [Abstract] [Full Text] [Related]
